884 related articles for article (PubMed ID: 18064932)
1. [Hirsutism].
van Zuuren EJ; Pijl H
Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
3. Hirsutism and virilism in women.
Kirschner MA
Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
[TBL] [Abstract][Full Text] [Related]
4. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
5. Spironolactone as a single agent for long-term therapy of hirsute patients.
Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
[TBL] [Abstract][Full Text] [Related]
6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
7. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
Prelević GM; Puzigaća Z; Balint-Perić LA
Ann N Y Acad Sci; 1993 May; 687():255-62. PubMed ID: 8323181
[No Abstract] [Full Text] [Related]
8. Therapeutic alternatives for the hirsute woman.
Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
[TBL] [Abstract][Full Text] [Related]
9. The treatment of polycystic ovary syndrome.
Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
[TBL] [Abstract][Full Text] [Related]
11. Hirsutism - from diagnosis to use of antiandrogens.
Unluhizarci K; Karaca Z; Kelestimur F
Front Horm Res; 2013; 40():103-14. PubMed ID: 24002408
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism.
Falsetti L; Pasinetti E; Ceruti D
Acta Eur Fertil; 1994; 25(5):303-6. PubMed ID: 7660719
[TBL] [Abstract][Full Text] [Related]
13. The clinical evaluation of hirsutism.
Somani N; Harrison S; Bergfeld WF
Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hirsutism and acne in hyperandrogenism.
Moghetti P; Toscano V
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):221-34. PubMed ID: 16772153
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
[TBL] [Abstract][Full Text] [Related]
16. Dermatology of androgen-related disorders.
Essah PA; Wickham EP; Nunley JR; Nestler JE
Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
[TBL] [Abstract][Full Text] [Related]
17. Management of hirsutism.
Alsantali A; Shapiro J
Skin Therapy Lett; 2009 Sep; 14(7):1-3. PubMed ID: 20039595
[TBL] [Abstract][Full Text] [Related]
18. The evaluation and management of hirsutism.
Azziz R
Obstet Gynecol; 2003 May; 101(5 Pt 1):995-1007. PubMed ID: 12738163
[TBL] [Abstract][Full Text] [Related]
19. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Kelekci KH; Kelekci S; Yengel I; Gul S; Yilmaz B
J Dermatolog Treat; 2012 Jun; 23(3):177-83. PubMed ID: 21254871
[TBL] [Abstract][Full Text] [Related]
20. [Hirsutism].
Rouiller DG
Rev Med Suisse; 2005 Feb; 1(6):420-4. PubMed ID: 15786646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
